Experienced in Angiosarcoma of the Liver

Jacques Irani

Paris, FR 
Experienced in Angiosarcoma of the Liver
Paris, FR 
OverviewLocationsClinical Research

Overview

Jacques Irani practices in Paris, France. Mr. Irani is rated as an Experienced expert by MediFind in the treatment of Angiosarcoma of the Liver. His top areas of expertise are Bladder Cancer, Prostate Cancer, Renal Cell Carcinoma (RCC), Cystectomy, and Reconstructive Urology Surgery.

His clinical research consists of co-authoring 182 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Angiosarcoma of the Liver.

Gender
Male

Locations

Paris, France
Other Locations
94270, France
CHU Henri Mondor
Creteil, France
Poitiers, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Medical Economics of Urinary PCA3 Test for Prostate Cancer Diagnosis
Medical Economics of Urinary PCA3 Test for Prostate Cancer Diagnosis
Enrollment Status: Completed
Publish Date: February 03, 2022
Intervention Type: Other
Study Phase: Not Applicable
Prospective Multicentric Evaluation of a Bladder Preservation Strategy Using a Combination of Neoadjuvant Chemotherapy and Optimal Bladder Transurethral Resection in Patients With a Urothelial Carcinoma
Prospective Multicentric Evaluation of a Bladder Preservation Strategy Using a Combination of Neoadjuvant Chemotherapy and Optimal Bladder Transurethral Resection in Patients With a Urothelial Carcinoma
Enrollment Status: Terminated
Publish Date: December 30, 2021
Intervention Type: Drug
Study Drug: Optimal TURB
Study Phase: Phase 2
View 1 Less Clinical Trial

182 Total Publications

BCG MEDAC® for the treatment of non-muscle invasive bladder tumors: Adverse events and predictive factors for tolerance.
BCG MEDAC® for the treatment of non-muscle invasive bladder tumors: Adverse events and predictive factors for tolerance.
Journal: The French journal of urology
Published: August 28, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Irani's expertise for a condition
ConditionClose
    View All 17 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile